Published in Curr Oncol on April 01, 2006
Carcinoid tumors. Oncologist (2008) 2.86
Consensus recommendations for the diagnosis and management of well-differentiated gastroenterohepatic neuroendocrine tumours: a revised statement from a Canadian National Expert Group. Curr Oncol (2010) 0.89
Recent trends in the treatment of well-differentiated endocrine carcinoma of the small bowel. World J Gastroenterol (2010) 0.89
Clinical practice guidelines and consensus statements in oncology--an assessment of their methodological quality. PLoS One (2014) 0.88
Metastatic carcinoid tumour mimicking cholecystitis, and a rare case of intussusception. BMJ Case Rep (2011) 0.88
Primary hepatic neuroendocrine tumor with multiple liver metastases: A case report with review of the literature. World J Gastroenterol (2015) 0.85
Appropriateness of systemic treatments in unresectable metastatic well-differentiated pancreatic neuroendocrine tumors. World J Gastroenterol (2015) 0.82
Quality of life, resource utilisation and health economics assessment in advanced neuroendocrine tumours: a systematic review. Eur J Cancer Care (Engl) (2013) 0.81
Chrysin suppresses achaete-scute complex-like 1 and alters the neuroendocrine phenotype of carcinoids. Cancer Gene Ther (2015) 0.80
Synergistic effect of pasireotide and teriflunomide in carcinoids in vitro. Neuroendocrinology (2012) 0.79
Clinicopathologic characteristics of colonic carcinoid tumors. J Surg Res (2013) 0.75
Eastern Canadian Gastrointestinal Cancer Consensus Conference 2014. Curr Oncol (2015) 0.75
Utility of ¹¹¹indium-pentetreotide scintigraphy in patients with neuroendocrine tumors. Ann Surg Oncol (2012) 0.75
Endoscopic mucosal resection with circumferential incision for treatment of rectal carcinoid tumours. World J Surg Oncol (2014) 0.75
Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas. Neoplasia (2017) 0.75
A 5-decade analysis of 13,715 carcinoid tumors. Cancer (2003) 12.78
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours. Gut (2005) 3.32
Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients. Circulation (1993) 3.29
Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms. Cancer (1991) 2.98
Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. J Am Coll Surg (2003) 2.88
The diagnosis and medical management of advanced neuroendocrine tumors. Endocr Rev (2004) 2.88
Factors associated with progression of carcinoid heart disease. N Engl J Med (2003) 2.57
Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system. Ann Oncol (2004) 2.54
Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS). Neuroendocrinology (2005) 2.49
Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin. Br J Cancer (1999) 2.40
Treatment with cisplatin and etoposide in patients with neuroendocrine tumors. Cancer (2001) 1.76
A 50-year analysis of 562 gastric carcinoids: small tumor or larger problem? Am J Gastroenterol (2004) 1.67
Carcinoid heart disease: presentation, diagnosis, and management. Heart (2004) 1.65
Carcinoid--a comprehensive review. Acta Oncol (2003) 1.63
Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms). Part I-general overview. Acta Oncol (2004) 1.62
Carcinoid heart disease. Correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography. Circulation (1995) 1.54
Surgical management for carcinoid tumors of small bowel, appendix, colon, and rectum. World J Surg (1996) 1.51
Trans-catheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors. Eur Radiol (2002) 1.51
Current management of gastrointestinal carcinoid tumors. J Gastrointest Surg (2004) 1.49
Hepatic surgery for metastases from neuroendocrine tumors. Surg Oncol Clin N Am (2003) 1.48
Tumor markers in neuroendocrine tumors. Digestion (2000) 1.38
Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors. J Clin Endocrinol Metab (2001) 1.37
Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms). Part II-specific NE tumour types. Acta Oncol (2004) 1.23
Carcinoid heart disease: relationship of circulating vasoactive substances to ultrasound-detectable cardiac abnormalities. Circulation (1988) 1.23
Interest of Chromogranin A for diagnosis and follow-up of endocrine tumours. Clin Endocrinol (Oxf) (2004) 1.18
Nuclear medicine in the detection, staging and treatment of gastrointestinal carcinoid tumours. Best Pract Res Clin Endocrinol Metab (2005) 1.18
Management of neuroendocrine liver metastases. Am J Surg (2004) 1.13
The spectrum of carcinoid tumours and carcinoid syndromes. Ann Clin Biochem (2003) 1.07
Echocardiographic and biochemical evaluation of the development and progression of carcinoid heart disease. J Am Coll Cardiol (1998) 1.06
Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours. Eur J Endocrinol (2004) 1.06
Interferon in the management of neuroendocrine GEP-tumors: a review. Digestion (2000) 1.00
Malignant carcinoids in the USA, SEER 1992-1999. An epidemiological study with 6830 cases. Eur J Cancer Prev (2003) 0.99
Role of neuropeptides and serotonin in the diagnosis of carcinoid tumors. Am J Med (1986) 0.96
Somatostatin receptor scintigraphy in patients with carcinoid tumors. World J Surg (1996) 0.94
Liver transplantation for neuroendocrine tumors. J Gastrointest Surg (2004) 0.93
Long-term survival of patients with small intestinal carcinoid tumors. World J Surg (2004) 0.91
Hepatic surgery for metastatic gastrointestinal neuroendocrine tumors. Cancer Control (2002) 0.91
Diagnosis and treatment of carcinoid tumors. Expert Rev Anticancer Ther (2003) 0.90
Importance of proliferation markers in gastrointestinal carcinoid tumors: a clinicopathologic study. Hepatogastroenterology (2001) 0.89
Comparative analysis of diagnostic techniques for localization of gastrointestinal neuroendocrine tumors. Yale J Biol Med (1999) 0.89
Tumour markers in neuroendocrine tumours. Ital J Gastroenterol Hepatol (1999) 0.89
Role of natriuretic peptides in the diagnosis and treatment of patients with carcinoid heart disease. Br J Cancer (2004) 0.87
Complications of midgut carcinoid tumors and carcinoid syndrome. Neuroendocrinology (2004) 0.87
Carcinoid Heart Disease. Curr Treat Options Cardiovasc Med (2000) 0.86
Incidence and morbidity of cholelithiasis in patients receiving chronic octreotide for metastatic carcinoid and malignant islet cell tumors. Cancer (1997) 0.85
Diagnosis of non-functioning neuro-endocrine gastro-enteropancreatic tumours. Neuroendocrinology (2004) 0.85
Cutaneous manifestations of the malignant carcinoid syndrome. Br J Dermatol (2005) 0.85
The value of somatostatin-receptor scintigraphy in newly diagnosed endocrine gastroenteropancreatic tumors. J Am Coll Surg (1997) 0.85
Surgical management of gastrointestinal carcinoid tumors. Adv Surg (1995) 0.82
Use of somatostatin receptor scintigraphy to image extrahepatic metastases of neuroendocrine tumors. Surgery (1998) 0.82
Functional imaging of malignant paragangliomas and carcinoid tumours. Eur J Nucl Med (2001) 0.80
Carcinoid tumor. Bratisl Lek Listy (2001) 0.78
Carcinoid heart disease: an update. Scand J Gastroenterol Suppl (2002) 0.78
Triple valve replacement in a patient with severe carcinoid heart disease. Cardiovasc Surg (2002) 0.77
Library of sequence-specific radioimmunoassays for human chromogranin A. Clin Chem (1999) 0.77
Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science (1985) 9.12
Measured enthusiasm: does the method of reporting trial results alter perceptions of therapeutic effectiveness? Ann Intern Med (1992) 7.65
Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med (1998) 7.60
Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J (1987) 7.32
Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol (1992) 7.14
Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J (1986) 6.62
A fusion protein required for vesicle-mediated transport in both mammalian cells and yeast. Nature (1989) 6.48
Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int (2007) 6.35
Multiple, distinct forms of bovine and human protein kinase C suggest diversity in cellular signaling pathways. Science (1986) 6.10
Sequence and analysis of chromosome 4 of the plant Arabidopsis thaliana. Nature (1999) 5.03
DNA purification and isolation using a solid-phase. Nucleic Acids Res (1994) 4.90
Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study. J Clin Oncol (2001) 4.89
A prospective study of venous thromboembolism after major trauma. N Engl J Med (1994) 4.87
Use of cardiac procedures and outcomes in elderly patients with myocardial infarction in the United States and Canada. N Engl J Med (1997) 4.84
A new enzyme superfamily - the phosphopantetheinyl transferases. Chem Biol (1996) 4.71
Structural alteration of viral homologue of receptor proto-oncogene fms at carboxyl terminus. Nature (1986) 4.70
A group of interacting yeast DNA replication genes. Genes Dev (1991) 4.45
Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev (2000) 4.24
The complete primary structure of protein kinase C--the major phorbol ester receptor. Science (1986) 4.02
Attention modulates synchronized neuronal firing in primate somatosensory cortex. Nature (2000) 3.93
Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group. N Engl J Med (1995) 3.92
Accumulation of chlorpyrifos on residential surfaces and toys accessible to children. Environ Health Perspect (1998) 3.75
Different pattern of codon recognition by mammalian mitochondrial tRNAs. Proc Natl Acad Sci U S A (1980) 3.74
Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. Roche Cooperative Oral Ganciclovir Study Group. N Engl J Med (1996) 3.63
Amelogenin-deficient mice display an amelogenesis imperfecta phenotype. J Biol Chem (2001) 3.50
Highly conserved core domain and unique N terminus with presumptive regulatory motifs in a human TATA factor (TFIID). Nature (1990) 3.42
Complete gene map of the plastid-like DNA of the malaria parasite Plasmodium falciparum. J Mol Biol (1996) 3.41
Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis. BMJ (2000) 3.10
Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J Virol (1991) 3.10
An islet of ability in autistic children: a research note. J Child Psychol Psychiatry (1983) 3.10
Changes in conserved region 2 of Escherichia coli sigma 70 affecting promoter recognition. J Mol Biol (1990) 3.04
Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis. Proc Natl Acad Sci U S A (2001) 3.04
Involvement of valosin-containing protein, an ATPase Co-purified with IkappaBalpha and 26 S proteasome, in ubiquitin-proteasome-mediated degradation of IkappaBalpha. J Biol Chem (1998) 2.80
Genital warts and cervical cancer. I. Evidence of an association between subclinical papillomavirus infection and cervical malignancy. Cancer (1982) 2.76
Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies. Antimicrob Agents Chemother (1998) 2.74
Practicing participatory research in American Indian communities. Am J Clin Nutr (1999) 2.72
Role of NADH/NADPH oxidase-derived H2O2 in angiotensin II-induced vascular hypertrophy. Hypertension (1998) 2.70
A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma. N Engl J Med (1996) 2.65
Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury. J Clin Invest (1998) 2.64
Mitochondrial DNA molecules and virtual number of mitochondria per cell in mammalian cells. J Cell Physiol (1988) 2.59
Sinusitis of the maxillary antrum. N Engl J Med (1975) 2.57
Nebulized wet aerosol treatment in emergency department--is it essential? Comparison with large spacer device for metered-dose inhaler. Chest (1997) 2.56
An exploratory qualitative study examining the social and psychological processes involved in regular dental attendance. J Public Health Dent (2000) 2.56
Idiopathic hypertrophic pachymeningitis. Neurology (2004) 2.55
Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system. Ann Oncol (2004) 2.54
LAT is essential for Fc(epsilon)RI-mediated mast cell activation. Immunity (2000) 2.48
The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex. N Engl J Med (1991) 2.48
[Primary structure of transfer RNA]. Biochimie (1972) 2.43
Oxygenation predicts radiation response and survival in patients with cervix cancer. Radiother Oncol (1998) 2.36
Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients. J Clin Invest (1998) 2.35
Identification of the pleiotropic sacQ gene of Bacillus subtilis. J Bacteriol (1986) 2.33
Null mutations in the SNF3 gene of Saccharomyces cerevisiae cause a different phenotype than do previously isolated missense mutations. Mol Cell Biol (1986) 2.30
Selective screening for gestational diabetes mellitus. Toronto Trihospital Gestational Diabetes Project Investigators. N Engl J Med (1997) 2.28
Infliximab for refractory ulcerative colitis. Am J Gastroenterol (2001) 2.26
A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas. Br J Cancer (2006) 2.23
Prevalence of Asperger's syndrome in a secure hospital. Br J Psychiatry (1994) 2.23
Enterotoxigenic Bacteroides fragilis: epidemiologic studies of its role as a human diarrhoeal pathogen. J Diarrhoeal Dis Res (1992) 2.23
Nonspecific bronchial reactivity in occupational asthma. J Allergy Clin Immunol (1979) 2.22
Protruding aortic arch atheromas: risk of stroke during heart surgery with and without aortic arch endarterectomy. Am Heart J (1999) 2.21
Structured exercise improves physical functioning in women with stages I and II breast cancer: results of a randomized controlled trial. J Clin Oncol (2001) 2.16
Four DAZ genes in two clusters found in the AZFc region of the human Y chromosome. Genomics (2000) 2.16
Catatonia in autistic spectrum disorders. Br J Psychiatry (2000) 2.15
Intestinal reperfusion injury is mediated by IgM and complement. J Appl Physiol (1985) (1999) 2.13
Evidence for linkage of bipolar disorder to chromosome 18 with a parent-of-origin effect. Am J Hum Genet (1995) 2.09
Interventional techniques in the management of chronic pain: Part 2.0. Pain Physician (2001) 2.09
Efficacy and safety of high-dose rhesus-human reassortant rotavirus vaccine in Native American populations. J Pediatr (1997) 2.07
Multiple metal contamination from house paints: consequences of power sanding and paint scraping in New Orleans. Environ Health Perspect (2001) 2.07
Socioeconomic inequalities in cancer survival in England after the NHS cancer plan. Br J Cancer (2010) 2.07
Misclassification of social disadvantage based on geographical areas: comparison of postcode and collector's district analyses. Int J Epidemiol (1995) 2.06
Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. Clin Exp Allergy (2013) 2.03
The effects of plasmalyte-148 vs. Hartmann's solution during major liver resection: a multicentre, double-blind, randomized controlled trial. Minerva Anestesiol (2014) 2.01
Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer. Int J Radiat Oncol Biol Phys (1993) 1.99
Mechanisms of hypersensitivity in IBS and functional disorders. Neurogastroenterol Motil (2007) 1.98
Sexually transmitted papillomaviral infections. I. The anatomic distribution and pathologic grade of neoplastic lesions associated with different viral types. Am J Obstet Gynecol (1987) 1.97
Early supplementary feeding and cognition: effects over two decades. Monogr Soc Res Child Dev (1993) 1.97
Distinct roles for the p110alpha and hVPS34 phosphatidylinositol 3'-kinases in vesicular trafficking, regulation of the actin cytoskeleton, and mitogenesis. J Cell Biol (1998) 1.97
STEAP: a prostate-specific cell-surface antigen highly expressed in human prostate tumors. Proc Natl Acad Sci U S A (1999) 1.96
Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia. Cochrane Database Syst Rev (2013) 1.91
Measurement of children's exposure to pesticides: analysis of urinary metabolite levels in a probability-based sample. Environ Health Perspect (2001) 1.91
XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results. Br J Cancer (2011) 1.90
Regulation of adenylate cyclase synthesis in Escherichia coli: nucleotide sequence of the control region. EMBO J (1983) 1.89
Two interleukin 1 genes in the mouse: cloning and expression of the cDNA for murine interleukin 1 beta. J Immunol (1986) 1.87
Suicide attempts in the Epidemiologic Catchment Area Study. Yale J Biol Med (1988) 1.86
Lymphangiomatosis. Histologic and immunohistochemical analysis of four cases. Am J Surg Pathol (1993) 1.84
Differential activation by atrial and brain natriuretic peptides of two different receptor guanylate cyclases. Nature (1989) 1.79
Noncondylomatous cervical wart virus infection. Obstet Gynecol (1980) 1.79
An immunodeficiency characterized by defective signal transduction in T lymphocytes. N Engl J Med (1989) 1.79
Capecitabine, an oral fluoropyrimidine carbamate with substantial activity in advanced colorectal cancer: results of a randomized phase II study. J Clin Oncol (2000) 1.77
Results of hepatic resection for sarcoma metastatic to liver. Ann Surg (2001) 1.75
Human atrial natriuretic peptide receptor defines a new paradigm for second messenger signal transduction. EMBO J (1989) 1.74
Effects of pulsed ultrasound on the mouse neonate: hind limb paralysis and lung hemorrhage. Ultrasound Med Biol (1994) 1.74
Genetic characterization of a mammalian protein-protein interaction domain by using a yeast reverse two-hybrid system. Proc Natl Acad Sci U S A (1996) 1.72
Sunitinib therapy for metastatic renal cell carcinoma: recommendations for management of side effects. Can Urol Assoc J (2007) 1.72
Quantitative determination of adenovirus-mediated gene delivery to rat cardiac myocytes in vitro and in vivo. Proc Natl Acad Sci U S A (1993) 1.72
Atlantoaxial instability in Down syndrome--guidelines for screening and detection. J R Soc Med (1990) 1.71
Oxygen sensing in the body. Prog Biophys Mol Biol (2005) 1.70